We evaluated whether a particular DRD2 polymorphism (rs 1076560, G > T), which codes for D2 dopamine receptors in the striatum, is associated with how well patients with Parkinson’s disease respond to exogenous administration of dopamine via L-DOPA (Kwak et al., 2012). This evidence concerns the gene DRD2 and Parkinson disease.